Hair loss research has moved well beyond a single mechanism. For years, most treatment conversations centered on one pathway, primarily hormonal, because that's where the most established treatments were directed. Newer research has broadened this picture considerably, looking at circulation, follicular signaling, and scalp inflammation as separate contributing factors, not just side notes to a hormonal explanation.
Understanding what current research actually shows, rather than what's commonly assumed, helps explain why some hair loss treatments work well for one person and poorly for another, even when both are dealing with what looks like the same pattern of thinning.
What does research say about hair loss beyond hormonal pathways?
Androgenetic alopecia, the most common form of hair loss, has traditionally been explained through the effect of dihydrotestosterone, or DHT, on hair follicles. This remains an important mechanism, but current research increasingly points to hair loss as a multi-factorial process. Studies have examined the role of follicular miniaturization independent of hormone levels, reduced blood flow to the scalp, chronic low-grade scalp inflammation, and oxidative stress, all of which can contribute to thinning even in the absence of a purely hormonal trigger.
This shift matters because it suggests that addressing hormonal activity alone may not be sufficient for everyone experiencing hair thinning, particularly in cases where inflammation or circulation appear to play a larger role.
What is known about follicular delivery and penetration?
A separate area of research has focused less on which ingredients affect hair growth and more on whether those ingredients ever reach the follicle in a meaningful concentration. The scalp, like skin elsewhere on the body, has its own barrier function, and topical formulations face the same delivery challenge seen in other areas of dermatology: an active ingredient sitting on the surface does very little if it can't actually penetrate to where hair growth is regulated.
This has led to growing interest in formulation techniques that specifically target follicular penetration, rather than relying on ingredient concentration alone to drive results.
What role does scalp health play in hair growth?
Research has increasingly treated the scalp as an extension of overall skin health rather than a separate category. Scalp conditions such as excess sebum, inflammation, or a disrupted microbiome have been associated with poorer hair growth outcomes, independent of hormonal status. This has shifted some research attention toward scalp-supportive ingredients, including antioxidants, anti-inflammatory compounds, and ingredients that support the hair shaft itself, alongside ingredients that address follicle-level signaling.
How does nanogrow™ apply this research?
This broader, multi-factorial understanding of hair loss is the foundation nanogrow™ is built on. Rather than relying on a single mechanism, it's formulated around a four-pathway architecture designed to target follicular penetration, hair loss, hair growth, hydration and scalp support, and shaft repair as separate but connected areas.
For hair loss and growth support, the formulation includes Nigella sativa, commonly known as black seed oil, along with Anagain and oat beta-glucan, ingredients that have been studied for their role in supporting the hair growth cycle. For hydration and follicular support, it includes Glucaveen™ and panthenol. For hair shaft repair, it uses Glaudin™ and saw palmetto, an ingredient that has drawn research interest for its potential role in addressing hormonal contributions to hair thinning without functioning as a systemic hormonal treatment.
Supporting actives such as niacinamide, polyglutamic acid, betaine and hydrolyzed vegetable protein round out the formulation, reflecting the broader research direction of treating hair growth as dependent on scalp condition and hair shaft integrity, not hormonal activity in isolation. nanogrow™ is positioned as a non-minoxidil option, which is relevant for people specifically looking for an approach built around this multi-pathway understanding rather than a single, long-established hormonal mechanism.
What other areas of dermatological research are worth watching?
Beyond hair loss, several other areas of dermatological research are actively evolving. Research into the skin and scalp microbiome continues to reshape how conditions like dandruff, eczema and acne are understood, moving away from treating them purely as surface-level issues. Formulation science is also increasingly focused on delivery technology, since research consistently shows that how an ingredient is delivered can matter as much as which ingredient
is used. These are active, ongoing areas of study, and current best practices continue to be shaped by new findings rather than settled once and for all.
A note from Monoskin
Dermatological research doesn't stand still, and treatments built around a single, older mechanism can miss what newer research has identified as equally important. Multi-pathway thinking, whether applied to hair loss, barrier repair or pigmentation, tends to reflect where the research has actually moved.
nanogrow™ reflects this shift for hair care specifically, built around several contributing factors rather than one. If hair thinning is significant, sudden, or accompanied by other symptoms, consult a dermatologist to determine the underlying cause and the most appropriate treatment approach.
